Driving research, innovation, and interdisciplinary excellence.
CIS has been established to offer an unique opening to advanced educational curriculum and research where the basic sciences meet with the technology to address the real challenges and pertinent issues for present society. Realizing the urgent need to fulfil the gap between academic curriculum and industry’s demands, CIS is offering a number of quality programs at post-graduate and research levels which will ultimately provide a talented pool of skilled manpower to ensure the working solution in the respective domains. Under the extraordinary leadership of Padma Shri (Prof.) Ajoy Kumar Ray, some of the best academicians and bright scholars have joined CIS as faculty members from India and across the globe.
Duration: 2 Years
Requirement | Details |
Qualification | BSc (with minimum 50% marks or equivalent CGPA) in Chemistry / Physics / Biochemistry / Life Sciences |
Duration: 2 Years
Requirement | Details |
Qualification |
BSc (with minimum 50% marks or equivalent CGPA) in Chemistry / Physics / Biochemistry / Life Sciences BE / BTech (with minimum 60% marks or equivalent CGPA) in relevant areas |
Duration: 3 Years
Requirement | Details |
Qualification |
Candidates having Bachelor’s Degree in Engineering / Masters Degree in Science (Chemistry / Physics / Biochemistry / Life Sciences or other Relevant Area). Working professionals will be preferred. |
Areas: Organic and Bio-Organic Chemistry / Medicinal Chemistry / Materials and 3D printing / Paint and coating technology / Biosensing and Sensor technology / Advanced material research / Immuno-Epigenetics / Nanomedicine / Nanomaterials and protein aggregation and allied domains
The Centre for Interdisciplinary Studies (CIS) is committed to emerging as a research group of global reach in the design and development of novel biomaterials, including polymeric and nanomaterials, along with sensor technology and IoT. The Centre emphasizes green and sustainable alternatives for cutting-edge industrial applications, while also fostering innovation and design science through the integration of interdisciplinary technologies.
CIS maintains strong collaborations with leading institutes and industries worldwide, including IIT Kharagpur, CSIR-IICB, MG University Kerala, NIPER Kolkata, SNBNCBS Kolkata, PDPU Gujarat, IIEST Shibpur, IPF Dresden (Germany), POSTECH (South Korea), Hongik University (South Korea), GUT (Poland), Georgia Institute of Technology (USA), Indian Paint Association (IPA), and Confederation of Indian Industry (CII).
PI: Dr. Subhankar Singha
Dr. Subhankar Singha’s research at JISIASR bridges fundamental organic chemistry with cutting-edge applications in healthcare and environmental monitoring through the development of smart fluorescent materials. The group designs novel fluorescent probes for biosensing, bioimaging, and drug delivery, including two-photon active fluorophores for high-resolution 3D imaging and portable sensor devices for environmental and biological sample analysis. A hydrogen sulfide probe has been commercialized by Merck Inc., showcasing translational impact.
PI: Prof. Sankarprasad Bhuniya
Prof. Sankarprasad Bhuniya’s work focuses on small-molecule fluorescent probes and theranostic agents for cancer detection and treatment. His group develops chemoselective, organelle-targeted probes for real-time monitoring of biological events and stimuli-responsive drug delivery systems. Recent efforts include multimodal imaging agents combining fluorescence, photoacoustic, and MRI for precise disease diagnosis and treatment monitoring.
PI: Dr. Barun Das
This study explores interactions between flavonoids and functionalized graphene-based materials using spectroscopic techniques and theoretical modeling (DFT). Insights into structural changes, bonding, and interaction energies pave the way for designing graphene-based platforms for drug delivery and biosensing applications.
PI: Dr. Pooja Ghosh
Dr. Pooja Ghosh’s research focuses on amyloid nanostructure-based hydrogels for 3D-printing biomedical scaffolds. These hydrogels demonstrate excellent mechanical stability, biodegradability, and biocompatibility, making them ideal for targeted drug delivery and wound healing applications, with promising results in cytotoxicity and hemocompatibility assays.
PI: Dr. Subhajit Ghosh
Dr. Subhajit Ghosh’s research addresses metal corrosion, a major economic issue in India, by developing cost-effective barrier coatings and novel corrosion inhibitors. These coatings, composed of resins, pigments, and solvents, offer compatibility with diverse substrates and aim to reduce corrosion-related GDP losses.
PI: Dr. Subhajit Ghosh
This project develops smart grafted polymer coatings for metallic orthopaedic implants to prevent metal ion leaching. These bioactive, biodegradable coatings are biocompatible, anticorrosive, and exhibit antibacterial properties, addressing challenges in bone and dental implant applications.
PI: Dr. Farhat Afrin
Dr. Farhat Afrin’s research explores nanomedicines, herbal therapeutics, and epigenetic modulation for diseases like cancer and leishmaniasis. The group develops liposomal vaccines, functional nanomedicines, and in silico drug repurposing strategies, alongside studying epigenetic alterations for novel therapeutic pathways.
PI: Dr. Subham Ghosh
Dr. Subham Ghosh’s research focuses on sustainable energy through high energy density Na-ion batteries. By optimizing electrode materials and electrolytes, the project aims to create durable, safe, and cost-effective batteries for energy storage in renewable energy systems and electric transport.
PI: Dr. Venkata Sundeep Seesala
The research explores hybrid fabrication techniques like green machining, 3D printing, casting, and molding to develop advanced gradient biomimetic architectures for titanium and zirconia implants. These designs mimic natural bone architecture, validated by computational, in vitro, and in vivo studies. Surface engineering with bioactive compounds like HA and Bioglass enhances osseointegration, stress distribution, and healing time, aiming to challenge foreign dominance in the Indian implants market.